Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Sales: 2011-2025

Historic Return on Sales for Ironwood Pharmaceuticals (IRWD) over the last 15 years, with Sep 2025 value amounting to 0.38%.

  • Ironwood Pharmaceuticals' Return on Sales rose 99.00% to 0.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.38%, marking a year-over-year increase of 99.00%. This contributed to the annual value of 0.29% for FY2024, which is 313.00% up from last year.
  • According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Return on Sales is 0.38%, which was up 26.28% from 0.30% recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' Return on Sales registered a high of 1.28% during Q3 2021, and its lowest value of -3.16% during Q1 2024.
  • Its 3-year average for Return on Sales is -0.91%, with a median of -0.55% in 2024.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Return on Sales slumped by 360bps in 2024 and then surged by 338bps in 2025.
  • Ironwood Pharmaceuticals' Return on Sales (Quarterly) stood at 1.28% in 2021, then slumped by 85bps to 0.43% in 2022, then tumbled by 327bps to -2.84% in 2023, then soared by 313bps to 0.29% in 2024, then soared by 99bps to 0.38% in 2025.
  • Its Return on Sales was 0.38% in Q3 2025, compared to 0.30% in Q2 2025 and 0.22% in Q1 2025.